Formulating DFG Budgets for Clinical Medicine & Trials

1. Financial Alignment & Eligibility Standards

Securing research funding from Deutsche Forschungsgemeinschaft (German Research Foundation) requires meticulous adherence to both financial eligibility standards and administrative regulations. For projects in the domain of Clinical Medicine & Trials, budgets must be constructed using realistic cost projections that are directly tied to the scientific methodology. Under-budgeting may jeopardise project execution, while over-budgeting or including ineligible costs often leads to immediate rejection during administrative screening.

For wet-lab research in Clinical Medicine & Trials, budget formulations must prioritize chemical reagents, specialized assay consumables, and pay-per-use core facility fees. Investigators should avoid pooling general office supplies with specialized scientific consumables to prevent auditing flags during reviews of DFG proposals.

Proposal teams must submit all budget items in the host institution's local currency, mapping them to the specific electronic submission environment (elan Portal). Every cost item must be justifiable as necessary, reasonable, and allocable to the project.

2. Direct vs. Indirect Cost Categorisation

A primary point of auditing compliance is the strict division between Direct Costs (expenses directly attributable to the execution of the research project) and Indirect Costs (institutional overheads, facility maintenance, and central administrative support).

Under active **DFG** guidelines, overhead recovery is computed as a flat 25% addition to eligible direct costs. Investigators must omit subcontracting expenditures from the calculation base when formulating indirect recovery for **Clinical Medicine & Trials** budgets.

For DFG proposals, the indirect cost rate is structured as: 22% flat-rate Programmpauschale. This rate must be applied correctly to the modified total direct cost base according to your institution's negotiated rate agreement or the flat rate set by the funder.

3. Step-by-Step Budget Justification Protocol

The budget justification (or budget narrative) is a critical component of the application reviewed by both financial auditors and peer reviewers. To draft a compliant narrative:

• Provide granular detail: Do not use lump sums. Break down personnel costs by calendar months or percentage of effort.
• Demonstrate direct linkage: For every cost, explain how it supports a specific task or objective in the research plan for Clinical Medicine & Trials.
• Cite institutional policies: Reference verified institutional rates for fringe benefits, travel mileage, and indirect cost bases to validate your numbers.
• Verify supplier quotes: For major equipment purchases or specialized laboratory assays, upload or reference formal vendor quotes.

Pre-Award Framework, Cost Sharing & Post-Award Governance

When preparing a funding proposal for the Deutsche Forschungsgemeinschaft (German Research Foundation) (DFG) inside the field of Clinical Medicine & Trials, mastering grant development and proactive pre-award grant management is an essential baseline step to clear administrative filters. Funding agencies like the DFG typically allocate resources through either categorical grants (strictly restricted to specified project budgets and detailed direct lines) or block grants (flexible institutional allocations with broad application scopes). When building the grant proposal timeline, the PI and co-principal investigator must ensure there is sufficient margin for institutional review and formal clearance of any cost sharing on grants. Effective project execution is governed by post-award grant management guidelines, which mandate establishing a robust subaward agreement research with co-investigators. Researchers must complete periodic effort certification research reports to satisfy DFG auditing and ensure that interdisciplinary team science research runs smoothly.

4. Frequently Asked Questions